alexa Strategy For Successful Regulatory Inspections In A Phase I Human Pharmacology Unit
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th World congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit
June 26-27, 2017 San Diego, USA

Sudheendra Kulkarni
Syngene Clinical Development, India
ScientificTracks Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X-C1-029
Abstract
Clinical Research Organizations (CRO) supporting the biopharmaceutical and pharmaceutical industry has seen a paradigm shift in how regulatory inspections are conducted. The current expectation is that the CRO has to demonstrate quality and data integrity (DI) in order to gain the trust of the regulatory investigators. Adherence to DI standards has become one of the key areas of focus during regulatory inspections. The systems used in the research industry have become more complex in terms of metadata that is being generated across the companies. Metadata that is created in a clinical trial is quite voluminous and the inspectors are aware of the possible DI issues that can arise from time-to-time. The functions such as user access, delete features data backup policies, audit trail, role of the system administrator, etc., have become the focus of attention during inspections. ALCOA principles are applicable to both paper and electronic data, thereby to ensure that the DI standards as part of good documentation practices (GDP) are followed uniformly by all personnel who generate clinical trial data. To ensure that the DI standards are maintained across the life cycle of the clinical trial, quality systems should be integrated and omnipresent in the operation to ensure the protocol, regulations and procedures are followed. Adherence to these standards will ensure that the clinical trial data generated will meet the applicable regulatory requirements. The current climate is such that, the DI requirements shall be more demanding and a primary focal point in clinical research. The focus of this presentation will highlight how we prepared the teams on the current global requirements to ensure a successful regulatory inspection.
Biography

Sudheendra K has his expertise in managing the GCP quality management systems at Syngene Clinical Development in the conduct of Phase I, bioequivalence, bioavailability studies. He has hosted many international regulatory inspections such as US FDA, EMA, ANVISA, Thailand GLP at Syngene Clinical Development. He is a trained Biochemist and has been associated with GCP QMS management for the last 14+ years. He has also audited many vendors and service providers who provide support for the contract research organizations for the conduct of early phase studies. He has also audited many complex clinical trials, Phase II and Phase III trials that have been conducted at different hospital sites.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords